000 01479 a2200445 4500
005 20250513213632.0
264 0 _c20001013
008 200010s 0 0 eng d
022 _a0391-4097
024 7 _a10.1007/BF03343730
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aRotondi, M
245 0 0 _aLong-term treatment with interferon-beta therapy for multiple sclerosis and occurrence of Graves' disease.
_h[electronic resource]
260 _bJournal of endocrinological investigation
_cMay 2000
300 _a321-4 p.
_bdigital
500 _aPublication Type: Case Reports; Journal Article
650 0 4 _aAdult
650 0 4 _aAutoantibodies
_xblood
650 0 4 _aFemale
650 0 4 _aGraves Disease
_xchemically induced
650 0 4 _aHumans
650 0 4 _aInterferon beta-1a
650 0 4 _aInterferon beta-1b
650 0 4 _aInterferon-beta
_xadministration & dosage
650 0 4 _aMultiple Sclerosis
_xdrug therapy
650 0 4 _aThyroid Gland
_ximmunology
650 0 4 _aThyroxine
_xblood
650 0 4 _aTriiodothyronine
_xblood
700 1 _aMazziotti, G
700 1 _aBiondi, B
700 1 _aManganella, G
700 1 _aDel Buono, A D
700 1 _aMontella, P
700 1 _adi Cristofaro, M
700 1 _aDi Iorio, G
700 1 _aAmato, G
700 1 _aCarella, C
773 0 _tJournal of endocrinological investigation
_gvol. 23
_gno. 5
_gp. 321-4
856 4 0 _uhttps://doi.org/10.1007/BF03343730
_zAvailable from publisher's website
999 _c10832702
_d10832702